These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14272630)

  • 41. [Effects of adjusting doses of diuretics at different time in treatment of advanced schistosomiasis ascites].
    Liu LQ; Zhang J; Tian YX
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Feb; 26(1):99-100, 105. PubMed ID: 24800582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Management of hepatic ascites using Fursemide].
    Bemvenuti GA; Job JM
    Hospital (Rio J); 1968 Nov; 74(5):1601-38. PubMed ID: 5305338
    [No Abstract]   [Full Text] [Related]  

  • 43. The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.
    Toniutto P; Pirisi M; Fabris C; Apollonio L; Sereti K; Bartoli EG
    Dig Dis Sci; 2006 Nov; 51(11):1992-7. PubMed ID: 17053959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [TREATMENT WITH DIURETICS OF THE EDEMA-ASCITES SYNDROME OF CIRRHOTICS].
    SCHRUB JC
    Concours Med; 1965 Jan; 87():351-8. PubMed ID: 14291482
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical observations on the efficacy of a new diuretic: furosemide].
    Branciari C; Lauro G; Menghini G
    Gazz Int Med Chir; 1965 Jul; 69(14):1203-14. PubMed ID: 5836956
    [No Abstract]   [Full Text] [Related]  

  • 46. THE STUDY OF THE EFFECT OF SPIROLACTONES ON ASCITES AND INTRASPLENIC PRESSURE IN BILHARZIAL LIVER CIRRHOSIS.
    ELMAHALLAWI MN; SAYED WA; EZZAT E
    J Egypt Med Assoc; 1963; 46():553-63. PubMed ID: 14066551
    [No Abstract]   [Full Text] [Related]  

  • 47. [CONSIDERATIONS ON THE USE OF THIAZIDE DIURETICS IN THE TREATMENT OF ASCITIC HEPATIC CIRRHOSIS].
    DEPASQUALE C; DIMODICA G; SCIVERES G
    Sicil Sanit; 1964; 17():23-8. PubMed ID: 14249627
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites.
    Kountouras J; Zavos C; Touloumis L; Chatzopoulos D
    Liver Int; 2010 Oct; 30(9):1395; author reply 1395-6. PubMed ID: 20731771
    [No Abstract]   [Full Text] [Related]  

  • 49. [DIURETIC THERAPY WITH FUROSEMIDE (LASIX)].
    MADULI S; CAMPANINI H; COMOLI G; GAMBIGLIANIZOCCOLI A
    Minerva Med; 1965 May; 56():1624-31. PubMed ID: 14325559
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic schemes for refractory ascites of advanced schistosomiasis: a clinical control study].
    He HR; Li M; Wei DP; Zhu JJ; Yang JB; Feng XH; Din W; Zhou RB; Lu GZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Oct; 24(5):570-2. PubMed ID: 23373268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trial of hydrochlorothiazide in ascites of bilharzial hepatolienal fibrosis.
    EL-EBRASHY N
    J Egypt Med Assoc; 1962; 45():430-9. PubMed ID: 13889773
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP; Molnár Z; Hartai A; Gercsák G
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of ascites in liver cirrhosis].
    Gramkow M; Christensen E
    Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
    Brater DC; Chalasani N; Gorski JC; Horlander JC; Craven R; Hoen H; Maya J
    Trans Am Clin Climatol Assoc; 2001; 112():108-15; discussion 116. PubMed ID: 11413770
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [CLINICAL EXPERIMENTATION WITH A NEW DIURETIC: 4-CHLORO-N-(2-FURFURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID (FUROSEMIDE)].
    MARCHESE G; STOCCHI F
    Minerva Med; 1965 May; 56():1612-7. PubMed ID: 14325555
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
    Brunner G; von Bergmann K; Häcker W; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CHEMICAL THERAPY OF CIRRHOSIS.
    CAPPS RB; JONES PN
    Biochem Clin; 1964; 3():203-8. PubMed ID: 14270161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.